Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7689
+0.0161 (2.14%)
Oct 23, 2025, 1:40 PM EDT - Market open
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $39.85 million as of October 23, 2025. Its market cap has increased by 13.34% in one year.
Market Cap
39.85M
Enterprise Value
-75.88M
1-Year Change
13.34%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $39.85M, a decrease of -90.66%. That is a compound annual growth rate of -44.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 39.02M | -7.06% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.69B |
| Johnson & Johnson | 463.00B |
| AbbVie | 404.45B |
| UnitedHealth Group | 326.88B |
| AstraZeneca | 259.95B |
| Novartis AG | 254.23B |
| Novo Nordisk | 237.27B |
| Abbott Laboratories | 219.99B |